Skip to content
Screener

Denali Therapeutics Inc. DNLI Gross Profit

Gross Profit at other companies

Eli Lilly logo
Eli LillyLLY
$19.71B+50.3%
uniQure logo
uniQureQURE
$5.49M+19.2%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$14.74M+49.4%

Other financials

Income statement

See full
Revenue$3.6M—
Operating income-$130.5M+3.3%
Net income-$127.6M-2.8%
EPS (diluted)-$0.68+5.6%

Balance sheet

See full
Cash & equivalents$204.6M+41.8%
Total debt$37.7M-21.4%
Total equity$835.2M-18.7%
Total assets$1.2B-0.7%

Cash flow

See full
Operating cash flow-$97.0M-28.8%
CapEx$805.0K-81.2%
Free cash flow-$97.8M-22.9%

Valuation

See full
Market cap$3.92B+88.3%
Enterprise value$3.76B+89.0%
P/S1,089×+1,084×

Profitability

See full
Operating margin-37,938%-37,986pp
Net margin-33,121.9%-33,159pp
FCF margin-31,736.3%-31,830pp

Returns & leverage

See full
Return on equity-54.9%+34.3pp
Debt / equity0×0.0×
Current ratio8.4×-1.9×

Where this comes from

Calculated from Denali Therapeutics Inc.’s reported figures.

$3.6Mtotal revenue−$93.0Ktotal cost of revenue=$3.51M

The source filing: Denali Therapeutics Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 4:08 PM EDT
Fiscal quarter
Q4 FY2026
Calendar quarter
Q4 2026
Accession
0001714899-26-000097

FAQ

What is Denali Therapeutics Inc.'s gross profit?
Denali Therapeutics Inc. (DNLI) reported gross profit of $3.51M in Q2 2026.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.

Ask your AI about Denali Therapeutics Inc.'s gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude